Labs / Assays & in vitro testing
ProtaGene
Dortmund, Germany · protagene.com
GMP · GLP · CLIA
ProtaGene is a contract research organization serving biopharmaceutical, cell therapy, and gene therapy developers. It provides analytical services for research through commercialization, with sites in Burlington, Massachusetts, and Dortmund, Heilbronn, and Heidelberg, Germany.
They take quote requests by email.
What they offer
Biotherapeutic Characterization Services
Provides protein characterization method development and analytical characterization covering structural assessment, biological activity, and product and process impurities for biotherapeutics.
Cell-Based Assays
Develops and runs cell-based assays to evaluate efficacy and safety, including molecule-specific assays tailored to client needs.
Manufacturing and QC
Supports manufacturing and quality control activities, including release testing for biopharmaceutical products.
Clinical Sample In Vivo CQA Mapping
Supports analytical work on clinical samples and in vivo critical quality attribute mapping.
Molecular Bioanalysis
Provides biodistribution, transgene expression, and vector shedding analyses for gene therapy development and clinical safety evaluation.
Integration Site Analysis
Analyzes vector integration sites for gene therapy programs using sensitive data analysis platforms.
Vector Characterization
Supports characterization of viral vectors and related safety and impurity assessments.
Long-Read Sequencing Services
Uses Oxford Nanopore sequencing to resolve complex genomic regions, structural variants, and transcript isoforms.
Bioinformatics – NGS Data Analytics
Provides bioinformatics analysis for NGS and sequencing-based projects.
Genome and Gene Editing
Offers analysis services related to genome and gene editing programs.
Gene Expression Quantitation
Measures gene expression levels for research and therapeutic development programs.
Commercial Patient Testing
Supports commercial-stage patient testing services.
Biologics Analytical Development
Provides analytical development support for biologic drug programs.
Biosimilar Testing
Performs analytical testing for biosimilar programs.
Cell & Gene Analytics
Offers integrated analytics for cell and gene therapy programs.
What they work on
- Modalities
- Antibody, Bispecific, ADC, Viral vector, Cell therapy, Gene editing, Biosimilar
- Species and models
- tissues, blood, biofluids
- Assays and studies
- forced degradation studies, product-related isoform and impurity analysis, comparability studies, primary sequence analysis, PTM analysis, disulfide linkage mapping, N-glycosylation analysis, amino acid analysis, extinction coefficient determination, size exclusion chromatography, biodistribution analysis, transgene expression analysis, and 3 more
- Instruments and platforms
- Oxford Nanopore sequencing technology, LC-MS, LC-MS/MS
- Scale and capacity
- four sites in Europe and North America
- Therapeutic areas
- biopharmaceuticals, cell therapy, gene therapy
- Type
- CRO
- Sites
- Burlington, Massachusetts, United States · Dortmund, Germany · Heilbronn, Germany · Heidelberg, Germany
- Quality
- ICH Q6B · GMP (Dortmund and Heilbronn sites; GMP lot release testing of commercial protein products) · GCP (Heidelberg and Boston sites, as appropriate) · GCLP (Heidelberg and Boston sites, as appropriate) · GLP (Heidelberg and Boston sites, as appropriate) · FDA 21 CFR Part 11 (audit trail requirements) · IVDR (Integration Site Analysis service components)
- Serves
- worldwide, Europe, North America, US, EMA
- Address
- 60 Blanchard Road Burlington, MA 01803 USA
- Founded
- 2021
Public records
- CLIA
- 99D2327251
- CMS CLIA laboratory
- 99D2327251 source
Similar labs. Evotec, Genevoyager, Biofidus GmbH, Hope Medicine (HopeMed)
Found in a contract services directory. Listing built from protagene.com. Work here? Claim this listing.